Dimetindene
DERMATOLOGICALS
Also known as: dimethindene, dimethindene maleate, dimetindene maleate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Dimetindene is a drug catalogued in DrugCentral. DrugCentral lists 6 molecular targets, including HRH1, CHRM2 and CHRM3.
- Molecular targets: HRH1, CHRM2, CHRM3 and CHRM1 (6 listed in DrugCentral).
- ATC code: D04AA13 (Antihistamines for topical use).
- Molecular formula: C20H24N2; molecular weight 292.43 g/mol.
Mechanism & targets
Molecular targets (6)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histamine H1 receptor | HRH1 | unknown | Ki 9.16 |
| Muscarinic acetylcholine receptor M2 | CHRM2 | unknown | Ki 7.35 |
| Muscarinic acetylcholine receptor M3 | CHRM3 | unknown | Ki 6.72 |
| Muscarinic acetylcholine receptor M1 | CHRM1 | unknown | Ki 6.58 |
| Muscarinic acetylcholine receptor M4 | CHRM4 | unknown | Ki 6.39 |
| Muscarinic acetylcholine receptor M5 | CHRM5 | unknown | Ki 6.10 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
D04AA13 | DERMATOLOGICALS › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › Antihistamines for topical use |
R06AB03 | RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Substituted alkylamines |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Polyneuropathy | 272.2 |
| COVID-19 | 201.2 |
| Drug ineffective | 73.1 |
| Renal pain | 67.6 |
| Anaemia | 66.2 |
| Leukopenia | 65.8 |
| Conjunctivitis | 65.4 |
| Dysgeusia | 65.0 |
| Vertigo | 62.9 |
| Coronavirus infection | 62.5 |
| Pyrexia | 54.7 |
| Osteochondrosis | 54.1 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Dimetindene is on its molecule page.
| Molecular formula | C20H24N2 |
|---|---|
| Molecular weight | 292.43 g/mol |
| CAS number | — |
| InChIKey | MVMQESMQSYOVGV-UHFFFAOYSA-N |
| PubChem CID | 21855 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Dimetindene work?
Its molecular targets in DrugCentral include HRH1, CHRM2, CHRM3 and CHRM1.
What is the chemical formula of Dimetindene?
Dimetindene has the molecular formula C20H24N2 and a molecular weight of 292.43 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 903 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1870768 — compound record and bioactivity
- PubChem CID 21855 — chemical identifiers
- DrugBank DB08801 — drug record
- FDA UNII 6LL60J9E0O — substance identity
- UniProt P35367 (HRH1) — target protein
- UniProt P08172 (CHRM2) — target protein
- UniProt P20309 (CHRM3) — target protein
- UniProt P11229 (CHRM1) — target protein
- UniProt P08173 (CHRM4) — target protein
- UniProt P08912 (CHRM5) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.